ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
Anebulo Pharmaceuticals Inc

Anebulo Pharmaceuticals Inc (ANEB)

1.53
-0.07
(-4.38%)
마감 05 2월 6:00AM
1.53
0.00
( 0.00% )
시간외 단일가: 6:00PM

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

주요 통계 및 세부정보

가격
1.53
매수가
1.26
매도가
1.91
거래량
-
0.00 일간 변동폭 0.00
0.8001 52주 범위 3.30
market_cap
전일 종가
1.53
개장가
-
최근 거래 시간
마지막 거래 시간
-
재정 규모
-
VWAP
-
평균 볼륨(3m)
31,889
발행 주식
25,933,217
배당수익률
-
주가수익률
-4.84
주당순이익(EPS)
-0.32
매출
-
순이익
-8.2M

Anebulo Pharmaceuticals Inc 정보

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of admini... Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
본부
Dover, Delaware, USA
설립됨
-
Anebulo Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker ANEB. The last closing price for Anebulo Pharmaceuticals was US$1.53. Over the last year, Anebulo Pharmaceuticals shares have traded in a share price range of US$ 0.8001 to US$ 3.30.

Anebulo Pharmaceuticals currently has 25,933,217 shares in issue. The market capitalisation of Anebulo Pharmaceuticals is US$39.68 million. Anebulo Pharmaceuticals has a price to earnings ratio (PE ratio) of -4.84.

ANEB 최신 뉴스

Anebulo Pharmaceuticals Announces Positive Regulatory Update for Selonabant in Acute Cannabis-Induced Toxicity in Children and Capital Raise

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid-induced toxicities (the “Company”...

Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2025 Financial Results and Recent Updates

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company” or...

Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Recent Updates

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company”...

Anebulo Pharmaceuticals Awarded NIDA Grant for its Investigational IV Treatment for Acute Cannabis-Induced Toxic Effects

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company”...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.042.684563758391.491.74861.42198921.59741128CS
40.01811.197169124941.51191.74861.39137001.57615203CS
120.010.6578947368421.521.80.8001318891.41128752CS
26-0.42-21.53846153851.953.080.8001181871.57854486CS
52-1.06-40.92664092662.593.30.8001121551.83680123CS
156-5.72-78.89655172417.257.880.8001105012.74899792CS
260-5.85-79.26829268297.389.330.8001112193.87661578CS

ANEB - Frequently Asked Questions (FAQ)

What is the current Anebulo Pharmaceuticals share price?
The current share price of Anebulo Pharmaceuticals is US$ 1.53
How many Anebulo Pharmaceuticals shares are in issue?
Anebulo Pharmaceuticals has 25,933,217 shares in issue
What is the market cap of Anebulo Pharmaceuticals?
The market capitalisation of Anebulo Pharmaceuticals is USD 39.68M
What is the 1 year trading range for Anebulo Pharmaceuticals share price?
Anebulo Pharmaceuticals has traded in the range of US$ 0.8001 to US$ 3.30 during the past year
What is the PE ratio of Anebulo Pharmaceuticals?
The price to earnings ratio of Anebulo Pharmaceuticals is -4.84
What is the reporting currency for Anebulo Pharmaceuticals?
Anebulo Pharmaceuticals reports financial results in USD
What is the latest annual profit for Anebulo Pharmaceuticals?
The latest annual profit of Anebulo Pharmaceuticals is USD -8.2M
What is the registered address of Anebulo Pharmaceuticals?
The registered address for Anebulo Pharmaceuticals is 838 WALKER ROAD, SUITE 21-2, KENT, DOVER, DELAWARE, 19904
What is the Anebulo Pharmaceuticals website address?
The website address for Anebulo Pharmaceuticals is www.anebulo.com
Which industry sector does Anebulo Pharmaceuticals operate in?
Anebulo Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
ESCAEscalade Inc
US$ 24.60
(64.11%)
1
OPOFOld Point Financial Corporation
US$ 39.51
(58.99%)
6
TWINTwin Disc Inc
US$ 17.88
(58.93%)
169
IBACIB Acquisition Corporation
US$ 16.24
(58.90%)
62
ADSEADD TEC Energy PLC
US$ 23.39
(56.66%)
12
SBFGSB Finanical Group Inc
US$ 12.22
(-46.85%)
10
THRYThryv Holdings Inc
US$ 10.01
(-46.01%)
4
AURAAura Biosciences Inc
US$ 5.01
(-37.38%)
1
LSBKLake Shore Bancorp Inc
US$ 11.01
(-30.23%)
1
INBXInhibrx Biosciences Inc
US$ 9.01
(-30.21%)
30
SXTP60 Degrees Pharmaceuticals Inc
US$ 0.8345
(39.78%)
21.12M
CYNCYNGN Inc
US$ 0.0809
(13.94%)
18.08M
UPCUniverse Pharmaceuticals Inc
US$ 0.3599
(33.35%)
12.92M
ASSTAsset Entities Inc
US$ 0.7135
(29.89%)
8.53M
SFHGSamfine Creation Holdings Group Ltd
US$ 1.445
(44.50%)
7.6M
SkeBallLarry SkeBallLarry 9 초 전
New name for the Gaza Strip >

* Area 47 * ...!!
DMC8 DMC8 30 초 전
https://x.com/icorvilud/status/1886833885306138787
AMRN
DocLee DocLee 36 초 전
Hi, Droid, I reckon that you must be "working" on piece work rates - 3 published messages in the space of 5 minutes. I just wonder how much money you have earned with those 3 Pulitzer Prize offerings.
NWBO
Jack Torrance Jack Torrance 3 분 전
https://x.com/DesFrontierTech/status/1886917173949407427
https://drive.google.com/file/d/1hu-7EbSN6JkI44Irx2oJkr4Slz6qG_lz/view

🚨🚀 BIG development for IonQ – A newly granted U.S. patent strengthens its tech moat in quantum computing. This is bullish for long-ter
IONQ
Homebrew Homebrew 4 분 전
There aren't any shorts.
shorts will be devastated...so sad
NBRI
Homebrew Homebrew 5 분 전
That joke's about 50 years old.
...MM signals...
NBRI
RobotDroid RobotDroid 6 분 전
So far, dumbest post of the day. The delay is due to a screwed up submission by Linda Worthless that they will not talk about thus the mute silence from the worlds worst ceo. You paid pumpers sure come up with some not creative fiction to explain the faults of nonmanagement. Grow a pair or rent some
NWBO
tenac tenac 6 분 전
Alan Jackson - I Want To Stroll Over Heaven With You
[yt]x-8iDUK2V8Q[/yt]
Uncle Monkey Uncle Monkey 8 분 전
so fsr today?
CBRF
nwsun nwsun 8 분 전
Since the debt pay off was on the last annual posted in the fall of 2023 and the dilution occurred after that ( didn't it begin showing up on OTC markets in December 2023), is it possible the amount of shares diluted was to reimburse the money Loyal paid out?
SFLM
RobotDroid RobotDroid 9 분 전
After all, mute, inept and full of GRIFT is the nwbo MO.
NWBO
subslover subslover 10 분 전
SunHydrogen Achieves Highest Known Efficiency for a Large-Area Hydrogen Module
Press Release | 02/05/2025
CORALVILLE, IA , Feb. 05, 2025 (GLOBE NEWSWIRE) -- SunHydrogen, Inc. (OTCQB: HYSR), the developer of a breakthrough technology to produce renewable hydrogen using sunlight and wate
HYSR
RobotDroid RobotDroid 10 분 전
It's where the dummies congregate.
NWBO
nwsun nwsun 12 분 전
Looking at a 5 year chart of this stock it looks like a bear etf.
ADTX
budfoxfun budfoxfun 12 분 전
"With our global patents and pending patents, we are revolutionizing environmental solutions for a sustainable future." https://thesustainablegreenteam.com/sgtm-home-page
SGTM
RobotDroid RobotDroid 12 분 전
Dream on, this will never ever happen.
NWBO
DoubleDouble DoubleDouble 13 분 전
https://investorshub.advfn.com/uimage/uploads/2025/2/5/nxjmuIMG_2977.jpeg
YBCN
WojD40 WojD40 14 분 전
Blame them for what? The ‘delay’ in a process that varies wildly in scope and complexity and was never assigned a deadline in the first place? I imagine the MAA is at least as complicated as building a house. How often does that happen ‘on time’? The company doesn’t update so as to avoid the kind of
NWBO
exwannabe exwannabe 15 분 전
• Drugs appearing on this list are typically those that are already approved or are expected to receive regulatory approval soon.
...
• If Mircidencel is still in the regulatory approval process, its inclusion in NHS documentation could indicate that approval is anticipated.
...
NWBO
floblu14 floblu14 16 분 전
Barbara Fiacco is a lawyer representing Enanta, correct? CORRECT!
She has represented leading pharmaceutical and life sciences clients in significant patent infringement lawsuits that have resulted in summary judgment or other favorable outcomes for her clients.

Also,
D
ENTA
Capt Caveman Capt Caveman 18 분 전
short volume percentage
10.61% 2-4-25

OTCShortReport.com

DBMM
DBMM
The ELTP King The ELTP King 18 분 전
********** NEW! **********

LOXAPINE SUCCINATE
ANDA #076868 SUPPL-12
ELITE LABS INC
Status: Labeling Approval

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076868
ELTP
TechandBio TechandBio 19 분 전
Should see the 60's! core holding in my IRA was $7.00 not that long ago need the foresight to really hit these home runs!
AKRO
jordan95 jordan95 21 분 전
They have a new post on x about this deal they're announcing I left a comment about the dilution happening
ASII